The Unified Protocol for the Treatment of Emotional Disorders in Spanish Public Mental Health System
Emotional Disorder, Anxiety Disorders, Depressive Disorder
About this trial
This is an interventional treatment trial for Emotional Disorder focused on measuring Unified Protocol, Transdiagnostic approach, Public health
Eligibility Criteria
Inclusion Criteria:
- Anxiety or mood disorder is the main diagnosis
- The patient is over 18 years of age
- The patient is fluent in the language in which the therapy is performed (Spanish in the present study)
- The patient is able to attend to the evaluation and treatment sessions
- The patient signs the informed consent form
Exclusion Criteria:
- The patient presents a severe mental disorder (bipolar disorder, schizophrenia, or an organic mental disorder) or there is suicide risk at the time of assessment
- The patient has used substances in the last three months (excluding cannabis, coffee, and / or nicotine)
- The patient has previously received 8 or more sessions of psychological treatment with clear and identifiable CBT principles
Sites / Locations
- Hospital General Universitario de EldaRecruiting
- Clínica de NavarraRecruiting
- Hospital Comarcal de VinaròsRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
Unified Protocol (UP)
Treatment As Usual (TAU)
Investigators in the present study have adapted the UP to implement it in group format in a Public Mental Health setting in Spain. This adaptation is composed of 12 treatment sessions of two hours of duration each, at a rate of one per week. Participants in the UP will receive UP treatment in group format instead of the usual Cognitive Behavioral Therapy in individual format. Patients in the UP condition will receive pharmacological treatment (i.e., antidepressants and / or anxiolytics) as usual.
Cognitive Behavioral Therapy in individual format is the treatment of choice (TAU) by psychologists and psychiatrists at the collaborating Public Mental Health Centers and Primary Care Centers, together with pharmacological treatment (i.e., antidepressants and / or anxiolytics).